Neuropsychological dysfunction in bipolar affective disorder: A critical opinion

Bipolar Disorders

Volumn 7, Issue 3, 2005, Pages 216-235

  Savitz, Jonathan ^a   Solms, Mark ^a   Ramesar, Rajkumar ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Bipolar disorder; Cognitive impairment; Endophenotype; Euthymic; Neurocognitive; Neurodegenerative; Neurodevelopmental; Neuroimaging; Neuropsychological

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBAMAZEPINE; CATECHOL METHYLTRANSFERASE; LITHIUM SALT; METHIONINE; MOOD STABILIZER; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALINE; VALPROIC ACID;

ALCOHOLISM; AMINO ACID SUBSTITUTION; ATTENTION; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN METABOLISM; COGNITIVE DEFECT; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EXPOSURE; ELECTROCONVULSIVE THERAPY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITY; HUMAN; IATROGENIC DISEASE; LEARNING DISORDER; MEMORY DISORDER; MENTAL PERFORMANCE; NERVE CELL NETWORK; NERVE DEGENERATION; NEUROPSYCHOLOGY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REVIEW; TASK PERFORMANCE;

BIPOLAR DISORDER; BRAIN; COGNITION DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS;

EID: 20344398698     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2005.00203.x     Document Type: Review

References (205)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. Washington DC: American Psychiatric Association, 1994.
2. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet 2003; 123C: 48-58.
3. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003; 60: 497-502.
4. Ferrier IN, Stanton BR, Kelly TP, Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999; 175: 246-251.
5. Clark L, Iverson SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180: 313-319.
6. Harmer CJ, Clark L, Grayson L, Goodwin GM. Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise. Neuropsychologia 2002; 40: 1586-1590.
7. Jones BP, Duncan CC, Mirsky AF, Post RM, Theodore WH. Neuropsychological profiles in bipolar affective disorder and complex partial seizure. Neuropsychology 1994; 8: 55-64.
8. Ali SO, Denicoff KD, Altshuler LL et al. A preliminary study of the relation of neuropsychological performance to neuroanatomic structures in bipolar disorder. Neuropsychiatry Neuropsychol Behav Neurol 2000; 13: 20-28.
9. van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. Arch Gen Psychiatry 1998; 55: 41-46.
10. van Gorp WG, Altshuler L, Theberge DC, Mintz J. Declarative and procedural memory in bipolar disorder. Biol Psychiatry 1999; 46: 525-531.
11. Cavanagh JTO, Van Beck M, Muir W, Blackwood DHR. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002; 180: 320-326.
12. Lebowitz BK, Shear PK, Steed MA, Strakowski SM. Verbal fluency in mania: relationship to number of manic episodes. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14: 177-182.
13. Tham A, Engelbrektson K, Mathe AA, Johnson L. Impaired neuropsychological performance in euthymic patients with recurring mood disorders. J Clin Psychiatry 1997; 58: 26-29.
14. Hawkins KA, Hoffman RE, Quinlan DM, Rakfeldt J, Docherty NM, Sledge WH. Cognition, negative symptoms, and diagnosis: a comparison of schizophrenic, bipolar and control samples. J Neuropsychiatry Clin Neurosci 1997; 9: 81-89.
15. Sapin LR, Berrettim WH, Nurnberger JI Jr, Rothblat LA. Mediational factors underlying cognitive changes and laterality in affective illness. Biol Psychiatry 1987; 22: 979-986.
16. Friedman L, Findling RL, Kenny JT et al. An MRI study of adolescent patients with either schizophrenia or bipolar disorder as compared to healthy control subjects. Biol Psychiatry 1999; 46: 78-88.
17. Kessing LV. Cognitive impairment in the euthymic phase of affective disorder. Psychol Med 1998; 28: 1027-1038.
18. Krabbendam L, Honig A, Wiersma J et al. Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiatr Scand 2000; 101: 274-280.
19. Winokur G, Coryell W, Akiskal HS, Endicott J, Keller M, Mueller T. Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. Acta Psychiatr Scand 1994; 89: 102-110.
20. Harrison PJ. The neuropathology of primary mood disorder. Brain 2002; 125: 1428-1449.
21. Weintrieb RM, O'Brien CP. Persistent cognitive deficits attributed to substance abuse. Neurol Clin: Neurol Complicat Drug Alcohol Abuse 1993; 11: 663-690.
22. Butters N, Cermak LS, Montgomery K, Adinolfi A. Some comparisons of the memory and visuoperceptive deficits of chronic alcoholics and patients with Korsak-off's disease. Alcoholism 1980; 1: 73-80.
23. Parsons OA, Nixon SJ. Neurobehavioral sequelae of alcoholism. Neurol Clin 1993; 11: 205-218.
24. Zubieta JK, Huguelet P, O'Neil RL, Giordani BJ. Cognitive function in euthymic bipolar I disorder. Psychiatry Res 2001; 102: 9-20.
25. Atre-Viadya N, Taylor MA, Seidenberg M, Reed R, Perrine A, Glick-Oberwise F. Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder. Neuropsychiatry Neuropsychol Behav Neurol 1998; 11: 120-126.
26. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003; 64: 86-93.
27. Squire LR, Judd LL, Janowsky DS et al. Effects of lithium carbonate on memory and other cognitive functions. Am J Psychiatry 1980; 137: 1042-1046.
28. Kocsis JH, Shaw ED, Stokes PE et al. Neuropsychologic effects of lithium discontinuation. J Clin Psychopharmacol 1993; 13: 268-275.
29. Honig A, Arts B, Ponds R et al. Lithium-induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice. Int Clin Psychopharmacol 1999; 14: 167-171.
30. Thompson PJ, Trimble MR. Anticonvulsant drugs and cognitive functions. Epilepsia 1982; 23: 531-544.
31. King DJ. Psychomotor impairment and cognitive disturbance induced by neuroleptics. Acta Psychiatr Scand 1994; 89: S53-S58.
32. Stein RA, Strickland TL. A review of the neuropsychological effects of commonly used prescription medications. Arch Clin Neuropsychol 1998; 13: 259-284.
33. Crews WD Jr, Harrison DW, Rhodes RD. Neuropsychological test performances of young depressed outpatient women: an examination of executive functions. Arch Clin Neuropsychol 1999; 14: 517-529.
34. Engelsmann F, Katz J, Ghadirian AM, Schachter D. Lithium and memory: a long-term follow-up study. J Clin Psychopharmacol 1988; 8: 207-211.
35. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000; 48: 813-828.
36. Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 2000; 48: 740-754.
37. Murphy FC, Sahakian BJ. Neuropsychology of bipolar disorder. Br J Psychiatry 2001; 41: s120-s127.
38. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 2001; 3: 106-150.
39. Chen YW, Dilsaver SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry 1996; 39: 896-899.
40. Sher L, Oquendo MA, Mann JJ. Risk of suicide in mood disorders. Clin Neurosci 2001; 1: 337-344.
41. Henry GM, Weingartner H, Murphy DL. Influence of affective states and psychoactive drugs on verbal learning and memory. Am J Psychiatry 1973; 130: 966-971.
42. Miller WR. Psychological deficit in depression. Psychol Bull 1975; 82: 238-260.
43. Sternberg DE, Jarvik ME. Memory functions in depression. Arch Gen Psychiatry 1976; 33: 219-224.
44. Cohen RM, Weingartner H, Smallberg SA, Pickar D, Murphy DL. Effort and cognition in depression. Arch Gen Psychiatry 1982; 39: 593-597.
45. Cole KD, Zarit SH. Psychological deficits in depressed medical patients. J Nerv Ment Dis 1984; 172: 150-155.
46. Elliot R, Sahakian BJ, McKay AP et al. Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance. Psychol Med 1996; 26: 975-989.
47. Elliot R, Baker SC, Rogers RD et al. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol Med 1997; 27: 931-942.
48. Hockey R. Stress and the cognitive components of skilled performance. In: Hamilton V, Warburton D eds. Human Stress and Cognition. Chichester: Wiley, 1986: 141-178.
49. Keitner GI, Solomon DA, Ryan CE et al. Prodromal and residual symptoms in bipolar I disorder. Comp Psychiatry 1996; 37: 362-367.
50. Zielinsky CM, Taylor MA, Juzwin KR. Neuropsychological deficits in obsessive compulsive disorder. Neuropsychiatry Neuropsychol Behav Neurol 1991; 4: 110-126.
51. Naismith SI, Hickie IB, Turner K et al. Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. J Clin Exp Neuropsychol 2003; 25: 866-877.
52. McEwen BS. The neurobiology and neuroendocrinology of stress: implications for post-traumatic stress disorder from a basic science perspective. Psychiatr Clin N Am 2002; 25: 469-494.
53. Bohnen N, Houx P, Nicolson N, Jolles J. Cortisol reactivity and cognitive performance in a continuous mental task paradigm. Biol Psychol 1990; 31: 107-116.
54. Bohnen N, Jolles J, Twijnstra A, Mellink R, Sulon J. Coping styles, cortisol reactivity, and performance in a vigilance task of patients with persistent post-concussive symptoms after mild head injury. Int J Neurosci 1992; 64: 97-105.
55. Altshuler L. Bipolar disorder: are repeated episodes associated with neuroanatomic and cognitive changes? Biol Psychiatry 1993; 33: 563-565.
56. McKay AP, Tarbuck AF, Shapleske J, McKenna PJ. Neuropsychological function in manic-depressive psychosis evidence for persistent deficits in patients with chronic severe illness. Br J Psychiatry 1995; 167: 51-57.
57. Goldberg TE, Gold JM, Greenberg R et al. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry 1993; 150: 1355-1362.
58. Clark LD, Iversen SD, Goodwin G. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry 2001; 158: 1605-1611.
59. Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161: 262-270.
60. Soares JC, Mann JJ. The functional neuroanatomy of mood disorders. J Psychiatr Res 1997; 31: 393-432.
61. Drevets WC, Price JL, Simpson JR Jr et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-S27.
62. Pizzagalli DA, Oakes TR, Fox AS et al. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry 2004; 9: 393-405.
63. Mayberg HS, Lewis PJ, Regenold W, Wagner HN Jr. Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994; 35: 929-934.
64. Mayberg HS, Liotti M, Brannan SK et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000; 48: 830-843.
65. Dolan RJ, Bench CJ, Brown RG, Scott LC, Frackowiak RS. Neuropsychological dysfunction in depression: the relationship to regional cerebral blood flow. Psychol Med 1994; 24: 849-857.
66. Kruger SH, Seminowicz D, Goldapple K, Kennedy SH, Mayberg HS. State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biol Psychiatry 2003; 54: 1274-1283.
67. Blumberg HP, Leung HC, Skudlarski P et al. A functional magnetic resonance imaging study of bipolar disorder. Arch Gen Psychiatry 2003; 60: 601-609.
68. Blumberg HP, Stern E, Ricketts S et al. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry 1999; 156: 1986-1988.
69. Blumberg HP, Stern E, Martinez D et al. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry 2000; 48: 1045-1052.
70. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. Ann Rev Psychol 2002; 53: 545-574.
71. Nobler MS, Sackheim HA, Prohovnik I et al. Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. Arch Gen Psychiatry 1994; 51: 884-897.
72. Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional blood flow on recovery from depression. Psychol Med 1995; 25: 247-261.
73. Mayberg HS, Liotti M, Brannan SK et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156: 675-682.
74. Holthoff VA, Beuthien-Baumann B, Zundorf G et al. Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand 2004; 110: 184-194.
75. Mayberg HS. Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci 1994; 6: 243-250.
76. Liotti M, Mayberg HS. The role of functional neuroimaging in the neuropsychology of depression. J Clin Exp Neuropsychol 2001; 23: 121-136.
77. Bradshaw JL, Sheppard DM. The neurodevelopmental frontostriatal disorders: evolutionary adaptiveness and anomalous lateralisation. Brain Lang 2000; 73: 297-320.
78. Chang K, Adleman NE, Dienes K, Sineonova DI, Menon V, Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder. Arch Gen Psychiatry 2004; 61: 781-792.
79. Wilder-Willis KE, Sax KW, Rosenborg HL, Fleck DE, Shear PK, Strakowski SM. Persistent attentional dysfunction in remitted bipolar disorder. Bipolar Disord 2001; 3: 58-62.
80. Liu SK, Chiu CH, Chang CJ, Hwang TJ, Hwu HG, Chen WJ. Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. Am J Psychiatry 2002; 159: 975-982.
81. Lezak MD. Neuropsychological Assessment, 3rd edn. London: Oxford University, 1995.
82. Chang K, Steiner H, Ketter T. Studies of offspring of parents with bipolar disorder. Am J Med Genet 2003; 123C: 26-35.
83. Faraone SV, Biederman J, Mennin D, Wozniak J, Spencer T. Attention deficit hyperactivity disorder with bipolar disorder: a familial subtype? J Am Acad Child Adolesc Psychiatry 1997; 36: 1378-1387.
84. Rubinsztein JS, Michael A, Paykel ES, Sahakian BJ. Cognitive impairment in remission in bipolar affective disorder. Psychol Med 2000; 30: 1025-1036.
85. Tsuang MT, Woolson RF, Fleming JA. Long-term outcome of major psychoses. I. Schizophrenia and affective disorders compared with psychiatrically symptom free surgical conditions. Arch Gen Psychiatry 1979; 36: 1295-1301.
86. Scott J, Stanton B, Garland A, Ferrier IN. Cognitive vulnerability in patients with bipolar disorder. Psychol Med 2000; 30: 467-472.
87. Soares JC, Mann JJ. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 1997; 41: 86-106.
88. Sheline YI. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 2003; 54: 338-352.
89. Videbech P. MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatr Scand 1997; 96: 157-168.
90. Salokangas RKR, Cannon T, Van Erp T et al. Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. Br J Psychiatry 2002; 181: s58-s65.
91. Steingard RJ, Renshaw PF, Yurgelun-Todd D et al. Structural abnormalities in brain magnetic resonance images of depressed children. J Am Acad Child Adolesc Psychiatry 1996; 35: 307-311.
92. Strakowski SM, DelBello MP, Zimmerman ME et al. Ventricular and periventricular structural volumes in first versus multiple episode bipolar disorder. Am J Psychiatry 2002; 159: 1841-1847.
93. Figiel GS, Krishnan KRR, Rao VP et al. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. J Neuropsychiatry Clin Neurosci 1991; 3: 18-22.
94. Botteron KN, Figiel GS, Wetzel MW, Hudziak J, Van Eerdewegh M. MRI abnormalities in adolescent bipolar affective disorder. J Am Acad Child Adolesc Psychiatry 1992; 31: 258-261.
95. Botteron KN, Vannier MW, Geller B, Todd RD, Lee BCP. Preliminary study of magnetic resonance imaging characteristics in 8 to 16 year-olds with mania. J Am Acad Child Adolesc Psychiatry 1995; 34: 742-749.
96. Strakowski SM, Woods BT, Tohen M, Wilson DR, Douglass AW, Stoll AL. MRI subcortical signal hyperintensities in mania at first hospitalisation. Biol Psychiatry 1993; 33: 204-206.
97. Aylward EH, Roberts Twillie JV, Barta PE et al. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 1994; 151: 687-693.
98. Dupont RM, Butters N, Schafer K, Wilson T, Hesselink J, Gillin JC. Diagnostic specificity of focal white matter abnormalities in bipolar and unipolar mood disorder. Biol Psychiatry 1995; 38: 482-486.
99. Lyoo IK, Lee HK, Jung JH, Noam GG, Renshaw PF. White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Comp Psychiatry 2002; 43: 361-368.
100. Pillai JJ, Friedman L, Stuve TA et al. Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder. Psychiatry Res 2002; 114: 51-56.
101. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders Proc Natl Acad Sci USA 1998; 95: 13290-13295.
102. Bouras C, Kovari E, Hof PR, Riederer BM, Giannakopolous P. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol 2001; 102: 373-379.
103. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial cell density characterise the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2001; 49: 741-752.
104. Cotter DR, Mackay D, Chana G, Beasley C, Landau S, Everall IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002; 12: 386-394.
105. Vawter MP, Freed WJ, Kleinman JE. Neuropathology of bipolar disorder. Biol Psychiatry 2000; 48: 486-504.
106. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry. Arch Gen Psychiatry 2002; 59: 553-558.
107. Lucassen PJ, Muller MB, Holsboer F et al. Hippocampal apoptosis in major depression is a minor event and absent from subareas of risk for glucocorticoid overexposure. Am J Pathol 2001; 158: 453-468.
108. Muller MB, Lucassen PJ, Yassouridis A, Hoogendijk WJG, Holsboer F, Swaab DF. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 2001; 14: 1603-1612.
109. Miguel-Hidalgo JJ, Rajkowska G. Morphological brain changes in depression. Can antidepressants reverse them? CNS Drugs 2002; 16: 361-372.
110. Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992; 32: 756-765.
111. Bourdeau I, Brad C, Noel B et al. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002; 87: 1949-1954.
112. Gilbert AP, Moore GJ, Keshavan MS et al. Decrease of thalamic volumes of pediatric patients with obsessive compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 2000; 57: 449-456.
113. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettwgrew JW. Changes in caudate volume with neuroleptic treatment. Lancet 1994; 344: 1434.
114. Chakos MH, Lieberman JA, Bilder RM et al. Increase in caudate nuclei volume of first-episode schizophrenia patients taking antipsychotic drugs. Am J Psychiatry 1994; 151: 1430-1436.
115. Gur RE, Cowell P, Turetsky BI et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 1998; 55: 145-152.
116. Madsen AL, Keidling N, Karle A et al. Neuroleptics in progressive structural brain abnormalities in psychiatric illness. Lancet 1998; 352: 784-785.
117. Denicoff KD, Ali SO, Mirsky AF et al. Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. J Affect Disord 1999; 56: 67-73.
118. El-Badri SM, Ashton CH, Moore PB, Marsh VR, Ferrier IN. Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord 2001; 3: 79-87.
119. DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax K. MRI analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology 1999; 21: 63-68.
120. MacQueen GM, Campbell S, McEwen BS et al. Course of illness, hippocampal function, and hippocampal volume in major depression Proc Natl Acad Sci USA 2003; 100: 1387-1392.
121. Hoff AL, Shukla S, Aronson T et al. Failure to differentiate bipolar disorder from schizophrenia on measures of neuropsychological function. Schiz Res 1990; 3: 253-260.
122. Verdoux H, Liraud F. Neuropsychological function in subjects with psychotic and affective disorders. Relationship to diagnostic category and duration of illness. Eur Psychiatry 2000; 15: 236-243.
123. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord 2003; 73: 261-269.
124. Paradiso S, Lamberty GJ, Garvey MJ, Robinson RG. Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Merit Dis 1997; 185: 748-754.
125. Austin MP, Mitchell P, Wilhelm K et al. Cognitive function in depression: a distinct pattern of frontal impairment in melancholia. Psychol Med 1999; 29: 73-85.
126. Albus M, Hubmann W, Wahlbeim C, Sobizack N, Franz U, Mohr F. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders. Acta Psychiatr Scand 1996; 94: 87-93.
127. Kato T, Shioiri T, Murashita J, Hamakawa H, Inubushi T, Takahashi S. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res 1994; 55: 41-50.
128. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149: 999-1010.
129. Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman GL. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993; 150: 720-727.
130. Strakowski SM, Adler CM, Holland SK, Mills NP, DelBello MP. A preliminary fMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology 2004; 29: 1734-1740.
131. Strakowski SM, DelBello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. 2005; 10: 105-116.
132. Ketter TA, Kimbrell TA, George MS et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 2001; 49: 97-109.
133. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997; 9: 471-481.
134. Gourovitch ML, Torrey EF, Gold JM, Randolph C, Weinberger DR, Goldberg TE. Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry 1999; 45: 639-646.
135. Noga JT, Vladar K, Torrey EF. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res 2001; 106: 25-34.
136. Kieseppa T, van Erp TGM, Haukka J et al. Reduced left hemispheric white matter volume in twins with bipolar I disorder. Biol Psychiatry 2003; 54: 896-905.
137. Tabares-Seisdedos R, Balanza-Martinez V, Salazar-Fraile J, Selva-Vera G, Leal-Cercos C, Gomez-Beneyto M. Specific executive/attentional deficits in patients with schizophrenia or bipolar disorder who have a positive family history of psychosis. J Psychiatr Res 2003; 37: 479-486.
138. Hirayasu V, Shenton ME, Salisbury DF et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999; 156: 1091-1093.
139. Crow TJ, Done DJ, Sacker A. Neurological abnormality in children who develop psychosis in adulthood. Schiz Res 1994; 11: 96.
140. van Os J, Jones P, Lewis G, Wadsworth M, Murray R. Developmental precursors of affective illness in a general population birth cohort. Arch Gen Psychiatry 1997; 54: 625-631.
141. Sigurdsson E, Fombonne E, Sayal K, Checkley S. Neurodevelopmental antecedents of early-onset bipolar affective disorder. Br J Psychiatry 1999; 175: 121-127.
142. Hellgren L, Gillberg IC, Bagenholm A, Gillberg C. Children with deficits in attention, motor control and perception (DAMP) almost grown up: psychiatric and personality disorders at age 16 years. J Child Psychol Psychiatry 1994; 35: 1255-1271.
143. Keri S, Kelemen O, Benedek G, Janka Z. Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychol Med 2001; 31: 915-922.
144. Chowdhury R, Ferrier IN, Thompson JM. Cognitive dysfunction in bipolar disorder. Curr Opin Psychiatry 2003; 16: 7-12.
145. Zalla T, Joyce C, Szoke A et al. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res 2004; 121: 207-217.
146. Kestenbaum CJ. Children at risk for manic-depressive illness: possible predictors. Am J Psychiatry 1979; 136: 1206-1208.
147. Decina P, Kestenbaum CJ, Farber S et al. Clinical and psychological assessment of children of bipolar probands. Am J Psychiatry 1983; 140: 548-553.
148. Flor-Henry P, Koles KA, Howarth BG, Burton L. Neurophysiology studies of schizophrenia, mania and depression. In: Gruzelier J ed. Hemisphere Asymmetries of Function in Psycholopathology. Amsterdam: Elsevier, 1979.
149. Ahearn EP, Steffens DC, Cassidy F et al. Familial leukoencephalopathy in bipolar disorder. Am J Psychiatry 1998; 155: 1605-1607.
150. Pierson A, Jouvent R, Quintin P, Perez-Diaz F, Leboyer M. Information processing deficits in relatives of manic depressive patients. Psychol Med 2000; 30: 545-555.
151. DelBello MP, Soutullo CA, Ryan P et al. MRI analysis of children at risk for bipolar disorder. Biol Psychiatry 2000; 47: 43.
152. DelBello MP, Geller G. Review of studies of child and adolescent offspring of bipolar parents. Bipolar Disord 2001; 3: 325-334.
153. Chang K, Steiner H, Dienes K, Adleman N, Ketter T. Bipolar offspring: a window into bipolar disorder evolution. Biol Psychiatry 2003; 53: 945-951.
154. Nopolous P, Torres I, Flaum M, Andreasen NC, Ehrhardt JC, Yuh WTC. Brain morphology in first-episode schizophrenia. Am J Psychiatry 1995; 152: 1721-1723.
155. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic Depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994; 31: 281-294.
156. McDonough-Ryan P, DelBello M, Shear PK, Ris MD, Soutullo C, Strakowski SM. Academic and cognitive abilities in children of parents with bipolar disorder: a test of the nonverbal learning disability model. J Clin Exp Neuropsychol 2002; 24: 280-285.
157. Kremen WS, Faraone SV, Seidman LJ, Pepple JR, Tsuang MT. Neuropsychological risk factors for schizophrenia: a preliminary study of female relatives of schizophrenic and bipolar probands. Psychiatry Res 1998; 79: 227-240.
158. Gilvarry C, Takei N, Russell A, Rushe T, Hemsley D, Murray RM. Premorbid IQ in patients with functional psychosis and their first degree relatives. Schiz Res 2000; 41: 417-429.
159. McNeil TF, Schubert EW. Do schizophrenia and bipolar disorder belong to the same neurobiological continuum? Neurodeviation in high-risk offspring from birth to adulthood. Schiz Res 2003; 60: 22.
160. Quackenbush D, Kutcher S, Robertson HA, Boulos C, Chaban P. Premorbid and postmorbid school functioning in bipolar adolescents: description and suggested academic interventions. Can J Psychiatry 1996; 41: 16-22.
161. Lagace DC, Kutcher SP, Robertson HA. Mathematics deficits in adolescents with bipolar I disorder. Am J Psychiatry 2003; 160: 100-104.
162. Kutcher S, Robertson HA, Bird D. Premorbid functioning in adolescent onset bipolar I disorder: a preliminary report from an ongoing study. J Affect Disord 1998; 51: 137-144.
163. Reichenberg A, Weiser M, Rabinowitz J et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry 2002; 159: 2027-2035.
164. Guerra A, Fearon P, Sham P et al. The relationship between predisposing factors, premorbid function and symptom dimensions in psychosis: an integrated approach. Eur Psychiatry 2002; 17: 311-320.
165. Chang K, Steiner H. Offspring studies in child and early adolescent bipolar disorder. In: Geller B, DelBello M eds. Bipolar Disorder in Childhood and Early Adolescence. New York: Guilford, 2003: 107-129.
166. Egan MF, Kojima M, Callicott JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
167. Egan MF, Goldberg TE, Kolachana BS et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922.
168. Hariri AR, Mattay VS, Tessitore A et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297: 400-403.
169. Li T, Vallada H, Curtis D et al. Catechol-O-methyltransferase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics 1997; 7: 349-353.
170. Kirov G, Murphy KC, Arranz MJ et al. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol Psychiatry 1998; 3: 342-345.
171. Bellivier F, Roy I, Leboyer M. Serotonin transporter gene polymorphisms and affective disorder-related phenotypes. Curr Opin Psychiatry 2002; 15: 49-58.
172. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-655.
173. Schulze TG, McMahon FJ. Genetic linkage and association studies in bipolar affective disorder: a time for optimism Am J Med Genet 2003; 123C: 36-47.
174. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001; 29: 306-309.
175. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003; 361: 598-604.
176. Brody JF. Evolutionary recasting: ADHD, mania, and its variants. J Affect Dis 2001; 65: 197-215.
177. Andreasen NC. Creativity and mental illness: prevalence rates in writers and their first-degree relatives. Am J Psychiatry 1987; 144: 1288-1292.
178. Jamison KR. Touched with Fire: Manic Depressive Illness and the Artistic Temperament. New York: Free Press, 1993.
179. Ludwig AM. Creative achievement and psychopathology: comparison among professions. Am J Psychother 1992; 46: 330-356.
180. Sulloway F. Born to Rebel: Birth Order, Family Dynamics, and Creative Lives. New York: Pantheon, 1994.
181. Goodwin F, Jamison KR. Manic Depressive Illness. New York: Oxford University Press, 1990.
182. Hammer M, Zubin J. Evolution, culture and psychopathology. J Gen Psychol 1968; 78: 151-164.
183. Isohanni I, Jarvelin MR, Jones P, Jokelainen J, Isohanni M. Can excellent school performance be a precursor of schizophrenia? A 28-year follow-up in the Northern Finland 1966 birth cohort. Acta Psychiatr Scand 1999; 100: 17-26.
184. Tsuchiya KJ, Agerbo E, Byrne M, Mortensen PB. Higher socio-economic status of parents may increase risk for bipolar disorder in offspring. Psychol Med 2004; 34: 787-793.
185. Glahn DC, Bearden CE, Niendam TA, Escamilla MA. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 2004; 6: 171-182.
186. Taylor J (ed.) Selected Writings of John Hughlings Jackson. Volume II. Evolution and Dissolution of the Nervous System. London: Hodder & Stoughton, 1932.
187. George MS, Ketter TA, Parekh PI et al. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci 1997; 9: 55-63.
188. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 2000; 101: 11-20.
189. Rubinsztein JS, Fletcher PC, Rogers RD et al. Decision-making
190. Martinez-Aran A, Penades R, Vieta E et al. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional out-come. Psychother Psychosom 2002; 71: 39-46.
191. Swann AC, Pazzaglia P, Nichols A, Dougherty DM, Moeller FG. Impulsivity and phase of illness in bipolar disorder. J Affect Disord 2003; 73: 105-111.
192. MacQueen GM, Young LT, Galway TM, Joffe RT. Backward masking task performance in stable, euthymic out-patients with bipolar disorder. Psychol Med 2001; 31: 1269-1277.
193. Thompson JM, Gray JM, Wilkinson BS et al. Impaired working memory monitoring on the Self-Ordered Pointing Task in euthymic bipolar patients. J Psychopharmacol 2001; 15: A67.
194. Thompson JM, Gray JM, Ferrier IN, Hughes JH, Watson S, Young AH. A component process analysis of working memory dysfunction in prospectively verified euthymic bipolar patients. Bipolar Disord 2001; 3: S60.
195. Thompson JM, Ferrier IN, Highes JH, Gray JM, Young AH. Neuropsychological function in a cohort of bipolar patients prospectively verified as euthymic. Acta Neuropsychiatr 2000; 12: 170.
196. Rossi A, Arduini L, Daneluzzo E, Bustini M, Prosperini P, Stratta P. Cognitive function in euthymic bipolar patients, stabilized schizophrenic patients, and healthy controls. J Psychiatr Res 2000; 34: 333-339.
197. Docherty NM, Hawkins KA, Hoffman RE, Quinlan DM, Rakfeldt J, Sledge WH. Working memory, attention, and communication disturbances in schizophrenia. J Abnorm Psychol 1996; 105: 212-219.
198. Coffman JA, Bornstein RA, Olson SC, Schwarzkopf SB, Nasrallah HA. Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 1990; 27: 1188-1196.
199. Waddington JL, Brown K, O'Neill J, McKeon P, Kinsella A. Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia. Psychol Med 1989; 19: 897-902.
200. Kerry RJ, McDermott CM, Orme JE. Affective disorders and cognitive performance. J Affect Disord 1983; 5: 349-352.
201. Lund Y, Nissen M, Rafaelsen OJ. Long-term lithium treatment and psychological functions. Acta Psychiatr Scand 1982; 65: 233-244.
202. Asarnow RF, MacCrimmon DJ. Span of apprehension deficits during the postpsychotic stage of schizophrenia. A replication and extension. Arch Gen Psychiatry 1981; 38: 1006-1011.
203. Savard RJ, Rey AC, Post RM. Halstead-Reitan category test in bipolar and unipolar affective disorders. J Nerv Ment Dis 1980; 168: 297-304.
204. Friedman MJ, Culver CM, Ferrell RB. On the safety of long-term treatment with lithium. Am J Psychiatry 1977; 134: 1123-1126.
205. Fossati P, Harvey PO, Le Bastard G, Ergis AM, Jouvent R, Allilaire JF. Verbal memory performance of patients with a first depressive episode and patients with unipolar and bipolar recurrent depression. J Psychiatr Res 2004; 38: 137-144.